GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curachem Co Ltd (XKRX:456190) » Definitions » Capex-to-Operating-Income

Curachem Co (XKRX:456190) Capex-to-Operating-Income : 0.00 (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Curachem Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Curachem Co's Capital Expenditure for the six months ended in . 20 was ₩0.00 Mil. Its Operating Income for the six months ended in . 20 was ₩0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Curachem Co Capex-to-Operating-Income Historical Data

The historical data trend for Curachem Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curachem Co Capex-to-Operating-Income Chart

Curachem Co Annual Data
Trend
Capex-to-Operating-Income

Curachem Co Semi-Annual Data
Capex-to-Operating-Income

Competitive Comparison of Curachem Co's Capex-to-Operating-Income

For the Biotechnology subindustry, Curachem Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curachem Co's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curachem Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Curachem Co's Capex-to-Operating-Income falls into.


;
;

Curachem Co Capex-to-Operating-Income Calculation

Curachem Co's Capex-to-Operating-Income for the fiscal year that ended in . 20 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- () /
=N/A

Curachem Co's Capex-to-Operating-Income for the quarter that ended in . 20 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curachem Co  (XKRX:456190) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Curachem Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Curachem Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Curachem Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
207, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Curachem Co Ltd is a manufacturing lab of radiolabeled compounds. Its main products include radiolabeled compounds used for in vivo absorption, distribution, metabolism, and excretion (ADME) studies, Phase I mass balance and micro-dosing (phase 0 and enhanced Phase I) research, and various works in a production facility, such as manufacturing, quality control, and quality assurance.

Curachem Co Headlines

No Headlines